Madlen Jentzsch (M Jentzsch)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 39

Top Venues

Leukemia

Cancers

Blood cancer journal

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Luise Fischer, Nora Grieb, Patrick Born, Ronald Weiss, Sabine Seiffert, Andreas Boldt, Stephan Fricke, Paul Franz, Simone Heyn, Anne-Sophie Kubasch, Ronny Baber, Heike Weidner, Song-Yau Wang, Enrica Bach, Sandra Hoffmann, Jule Ussmann, Janine Kirchberg, Saskia Hell, Sebastian Schwind, Klaus H Metzeler, Marco Herling, Madlen Jentzsch, Georg-Nikolaus Franke, Ulrich Sack, Kristin Reiche, Ulrike Köhl, Uwe Platzbecker, Vladan Vucinic, Maximilian Merz
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma. Leukemia 38 (2) (2024)
Sebastian Schwind, Lara Bischof, Marius Bill, Juliane Grimm, Jule Ussmann, Donata Backhaus, Dominic Brauer, Tung Pham Thanh, Maximilian Merz, Georg-Nikolaus Franke, Klaus H Metzeler, Vladan Vucinic, Marco Herling, Uwe Platzbecker, Madlen Jentzsch
Quantifying NPM1 MRD in AML patients prior to allogeneic stem cell transplantation: Where to draw the line? HemaSphere 8 (3) (2024)
Johannes Lübke, Deborah Christen, Juliana Schwaab, Anne Kaiser, Nicole Naumann, Khalid Shoumariyeh, Madlen Jentzsch, Katja Sockel, Judith Schaffrath, Francis A Ayuk, Matthias Stelljes, Inken Hilgendorf, Elisa Sala, Jennifer Kaivers, Stefan O Schönland, Christoph Wittke, Bernd Hertenstein, Markus Radsak, Ulrich Kaiser, Valeska Brückl, Nicolaus M Kröger, Tim H Brümmendorf, Wolf-Karsten Hofmann, Stefan Klein, Edgar Jost, Andreas Reiter, Jens Peter Panse
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries. Leukemia 38 (4) (2024)
Stefanie Jilg, Juliana Schwaab, Katja Sockel, Carl C Crodel, Valeska Brueckl, Frank Stegelmann, Madlen Jentzsch, Daniel Sasca, Margarete Moyses, Stephan Fuhrmann, Daniel Gundel, Madlen Caduc, Lino L Teichmann, Petro E Petrides, Haifa K Al-Ali, Florian H Heidel
MoReLife - real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients. Annals of hematology (2024)
Johannes Lübke, Deborah Christen, Juliana Schwaab, Anne Kaiser, Nicole Naumann, Khalid Shoumariyeh, Madlen Jentzsch, Katja Sockel, Judith Schaffrath, Francis A Ayuk, Matthias Stelljes, Inken Hilgendorf, Elisa Sala, Jennifer Kaivers, Stefan O Schönland, Christoph Wittke, Bernd Hertenstein, Markus Radsak, Ulrich Kaiser, Valeska Brückl, Nicolaus M Kröger, Tim H Brümmendorf, Wolf-Karsten Hofmann, Stefan Klein, Edgar Jost, Andreas Reiter, Jens Peter Panse
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries. Leukemia 38 (4) (2024)
Johannes Lübke, Deborah Christen, Juliana Schwaab, Anne Kaiser, Nicole Naumann, Khalid Shoumariyeh, Madlen Jentzsch, Katja Sockel, Judith Schaffrath, Francis A Ayuk, Matthias Stelljes, Inken Hilgendorf, Elisa Sala, Jennifer Kaivers, Stefan O Schönland, Christoph Wittke, Bernd Hertenstein, Markus Radsak, Ulrich Kaiser, Valeska Brückl, Nicolaus M Kröger, Tim H Brümmendorf, Wolf-Karsten Hofmann, Stefan Klein, Edgar Jost, Andreas Reiter, Jens Peter Panse
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries. Leukemia 38 (4) (2024)
Johannes Lübke, Deborah Christen, Juliana Schwaab, Anne Kaiser, Nicole Naumann, Khalid Shoumariyeh, Madlen Jentzsch, Katja Sockel, Judith Schaffrath, Francis A Ayuk, Matthias Stelljes, Inken Hilgendorf, Elisa Sala, Jennifer Kaivers, Stefan O Schönland, Christoph Wittke, Bernd Hertenstein, Markus Radsak, Ulrich Kaiser, Valeska Brückl, Nicolaus M Kröger, Tim H Brümmendorf, Wolf-Karsten Hofmann, Stefan Klein, Edgar Jost, Andreas Reiter, Jens Peter Panse
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries. Leukemia (2024)
Sebastian Schwind, Lara Bischof, Marius Bill, Juliane Grimm, Jule Ussmann, Donata Backhaus, Dominic Brauer, Tung Pham Thanh, Maximilian Merz, Georg-Nikolaus Franke, Klaus H Metzeler, Vladan Vucinic, Marco Herling, Uwe Platzbecker, Madlen Jentzsch
Quantifying NPM1 MRD in AML patients prior to allogeneic stem cell transplantation: Where to draw the line? HemaSphere 8 (3) (2024)
Luise Fischer, Nora Grieb, Patrick Born, Ronald Weiss, Sabine Seiffert, Andreas Boldt, Stephan Fricke, Paul Franz, Simone Heyn, Anne-Sophie Kubasch, Ronny Baber, Heike Weidner, Song-Yau Wang, Enrica Bach, Sandra Hoffmann, Jule Ussmann, Janine Kirchberg, Saskia Hell, Sebastian Schwind, Klaus H Metzeler, Marco Herling, Madlen Jentzsch, Georg-Nikolaus Franke, Ulrich Sack, Kristin Reiche, Ulrike Köhl, Uwe Platzbecker, Vladan Vucinic, Maximilian Merz
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma. Leukemia (2024)
Luise Fischer, Nora Grieb, Patrick Born, Ronald Weiss, Sabine Seiffert, Andreas Boldt, Stephan Fricke, Paul Franz, Simone Heyn, Anne-Sophie Kubasch, Ronny Baber, Heike Weidner, Song-Yau Wang, Enrica Bach, Sandra Hoffmann, Jule Ussmann, Janine Kirchberg, Saskia Hell, Sebastian Schwind, Klaus H Metzeler, Marco Herling, Madlen Jentzsch, Georg-Nikolaus Franke, Ulrich Sack, Kristin Reiche, Ulrike Köhl, Uwe Platzbecker, Vladan Vucinic, Maximilian Merz
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma. Leukemia 38 (2) (2024)
Luise Fischer, Nora Grieb, Patrick Born, Ronald Weiss, Sabine Seiffert, Andreas Boldt, Stephan Fricke, Paul Franz, Simone Heyn, Anne-Sophie Kubasch, Ronny Baber, Heike Weidner, Song-Yau Wang, Enrica Bach, Sandra Hoffmann, Jule Ussmann, Janine Kirchberg, Saskia Hell, Sebastian Schwind, Klaus H Metzeler, Marco Herling, Madlen Jentzsch, Georg-Nikolaus Franke, Ulrich Sack, Kristin Reiche, Ulrike Köhl, Uwe Platzbecker, Vladan Vucinic, Maximilian Merz
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma. Leukemia 38 (2) (2024)
Johannes Lübke, Deborah Christen, Juliana Schwaab, Anne Kaiser, Nicole Naumann, Khalid Shoumariyeh, Madlen Jentzsch, Katja Sockel, Judith Schaffrath, Francis A Ayuk, Matthias Stelljes, Inken Hilgendorf, Elisa Sala, Jennifer Kaivers, Stefan O Schönland, Christoph Wittke, Bernd Hertenstein, Markus Radsak, Ulrich Kaiser, Valeska Brückl, Nicolaus M Kröger, Tim H Brümmendorf, Wolf-Karsten Hofmann, Stefan Klein, Edgar Jost, Andreas Reiter, Jens Peter Panse
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries. Leukemia 38 (4) (2024)
Luise Fischer, Nora Grieb, Patrick Born, Ronald Weiss, Sabine Seiffert, Andreas Boldt, Stephan Fricke, Paul Franz, Simone Heyn, Anne-Sophie Kubasch, Ronny Baber, Heike Weidner, Song-Yau Wang, Enrica Bach, Sandra Hoffmann, Jule Ussmann, Janine Kirchberg, Saskia Hell, Sebastian Schwind, Klaus H Metzeler, Marco Herling, Madlen Jentzsch, Georg-Nikolaus Franke, Ulrich Sack, Kristin Reiche, Ulrike Köhl, Uwe Platzbecker, Vladan Vucinic, Maximilian Merz
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma. Leukemia (2024)
Luise Fischer, Nora Grieb, Patrick Born, Ronald Weiss, Sabine Seiffert, Andreas Boldt, Stephan Fricke, Paul Franz, Simone Heyn, Anne-Sophie Kubasch, Ronny Baber, Heike Weidner, Song-Yau Wang, Enrica Bach, Sandra Hoffmann, Jule Ussmann, Janine Kirchberg, Saskia Hell, Sebastian Schwind, Klaus H Metzeler, Marco Herling, Madlen Jentzsch, Georg-Nikolaus Franke, Ulrich Sack, Kristin Reiche, Ulrike Köhl, Uwe Platzbecker, Vladan Vucinic, Maximilian Merz
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma. Leukemia 38 (2) (2024)
Luise Fischer, Nora Grieb, Patrick Born, Ronald Weiss, Sabine Seiffert, Andreas Boldt, Stephan Fricke, Paul Franz, Simone Heyn, Anne-Sophie Kubasch, Ronny Baber, Heike Weidner, Song-Yau Wang, Enrica Bach, Sandra Hoffmann, Jule Ussmann, Janine Kirchberg, Saskia Hell, Sebastian Schwind, Klaus H Metzeler, Marco Herling, Madlen Jentzsch, Georg-Nikolaus Franke, Ulrich Sack, Kristin Reiche, Ulrike Köhl, Uwe Platzbecker, Vladan Vucinic, Maximilian Merz
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma. Leukemia 38 (2) (2024)
Luise Fischer, Nora Grieb, Patrick Born, Ronald Weiss, Sabine Seiffert, Andreas Boldt, Stephan Fricke, Paul Franz, Simone Heyn, Anne-Sophie Kubasch, Ronny Baber, Heike Weidner, Song-Yau Wang, Enrica Bach, Sandra Hoffmann, Jule Ussmann, Janine Kirchberg, Saskia Hell, Sebastian Schwind, Klaus H Metzeler, Marco Herling, Madlen Jentzsch, Georg-Nikolaus Franke, Ulrich Sack, Kristin Reiche, Ulrike Köhl, Uwe Platzbecker, Vladan Vucinic, Maximilian Merz
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma. Leukemia 38 (2) (2024)
Thomas Walter Georgi, Lars Kurch, Georg-Nikolaus Franke, Madlen Jentzsch, Sebastian Schwind, Carmen Perez-Fernandez, Naima Petermann, Maximilian Merz, Klaus H Metzeler, Gudrun Borte, Sandra Hoffmann, Marco Herling, Timm Denecke, Regine Kluge, Osama Sabri, Uwe Platzbecker, Vladan Vucinic
Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy. Journal of cancer research and clinical oncology (2023)
Lara Bischof, Jule Ussmann, Juliane Grimm, Marius Bill, Dominic Brauer, Donata Backhaus, Lisa Herrmann, Maximilian Merz, Marco Herling, Klaus H Metzeler, Georg-Nikolaus Franke, Vladan Vucinic, Uwe Platzbecker, Sebastian Schwind, Madlen Jentzsch
Prognostic impact of measurable residual clonal hematopoiesis in acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation. Leukemia (2023)
Anne-Sophie Kubasch, P Peterlin, Thomas Cluzeau, K S Götze, K Sockel, R Teipel, Madlen Jentzsch, H Attalah, M Sebert, F Chermat, S Gloaguen, M Puttrich, Michael Cross, Marie Schneider, S Kayser, D Schipp, A Giagounidis, I Tirado-Gonzalez, A Descot, Arjan A van de Loosdrecht, A Weigert, Klaus H Metzeler, P Fenaux, H Medyouf, Uwe Platzbecker, Lionel Ades
Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial. Leukemia (2023)
Madlen Jentzsch, Lara Bischof, Dominic Brauer, Donata Backhaus, Jule Ussmann, Georg-Nikolaus Franke, Vladan Vucinic, Uwe Platzbecker, Sebastian Schwind
Clinical Implications of the FLT3 -ITD Allelic Ratio in Acute Myeloid Leukemia in the Context of an Allogeneic Stem Cell Transplantation. Cancers 15 (4) (2023)
Madlen Jentzsch, Lara Bischof, Dominic Brauer, Donata Backhaus, Jule Ussmann, Georg-Nikolaus Franke, Vladan Vucinic, Uwe Platzbecker, Sebastian Schwind
Clinical Implications of the FLT3 -ITD Allelic Ratio in Acute Myeloid Leukemia in the Context of an Allogeneic Stem Cell Transplantation. Cancers 15 (4) (2023)
Madlen Jentzsch, Lara Bischof, Dominic Brauer, Donata Backhaus, Jule Ussmann, Georg-Nikolaus Franke, Vladan Vucinic, Uwe Platzbecker, Sebastian Schwind
Clinical Implications of the FLT3 -ITD Allelic Ratio in Acute Myeloid Leukemia in the Context of an Allogeneic Stem Cell Transplantation. Cancers 15 (4) (2023)
Donata Backhaus, Dominic Brauer, Rosmarie Pointner, Lara Bischof, Vladan Vucinic, Georg-Nikolaus Franke, Dietger Niederwieser, Uwe Platzbecker, Madlen Jentzsch, Sebastian Schwind
A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older. Bone marrow transplantation (2022)
Madlen Jentzsch, Lara Bischof, Jule Ussmann, Donata Backhaus, Dominic Brauer, Klaus H Metzeler, Maximilian Merz, Vladan Vucinic, Georg-Nikolaus Franke, Marco Herling, Uwe Platzbecker, Sebastian Schwind
Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation. Blood cancer journal 12 (12) (2022)
Marius Bill, Madlen Jentzsch, Lara Bischof, Jessica Kohlschmidt, Juliane Grimm, Laura Katharina Schmalbrock, Donata Backhaus, Dominic Brauer, Karoline Goldmann, Georg-Nikolaus Franke, Vladan Vucinic, Dietger Niederwieser, Alice S Mims, Uwe Platzbecker, Ann-Kathrin Eisfeld, Sebastian Schwind
Impact of IDH1 and IDH2 mutation detection at diagnosis and in remission in patients with AML receiving allogeneic transplantation. Blood advances (2022)
Luise Hartmann, Judith S Hecker, Maja Rothenberg-Thurley, Jennifer Rivière, Madlen Jentzsch, Bianka Ksienzyk, Michèle C Buck, Mark van der Garde, Luise Fischer, Susann Winter, Martina Rauner, Elena Tsourdi, Heike Weidner, Katja Sockel, Marie Schneider, Anne-Sophie Kubasch, Martin Nolde, Dominikus Hausmann, Jörg Lützner, Szymon Goralski, Florian Bassermann, Karsten Spiekermann, Lorenz C Hofbauer, Sebastian Schwind, Uwe Platzbecker, Katharina S Götze, Klaus H Metzeler
Compartment-specific mutational landscape of clonal hematopoiesis. Leukemia 36 (11) (2022)
Madlen Jentzsch, Lara Bischof, Jule Ussmann, Donata Backhaus, Dominic Brauer, Klaus H Metzeler, Maximilian Merz, Vladan Vucinic, Georg-Nikolaus Franke, Marco Herling, Uwe Platzbecker, Sebastian Schwind
Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation. Blood cancer journal 12 (12) (2022)
Madlen Jentzsch, Lara Bischof, Jule Ussmann, Donata Backhaus, Dominic Brauer, Klaus H Metzeler, Maximilian Merz, Vladan Vucinic, Georg-Nikolaus Franke, Marco Herling, Uwe Platzbecker, Sebastian Schwind
Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation. Blood cancer journal 12 (12) (2022)
Madlen Jentzsch, Lara Bischof, Donata Backhaus, Dominic Brauer, Julia Schulz, Georg-Nikolaus Franke, Vladan Vucinic, Dietger Niederwieser, Uwe Platzbecker, Sebastian Schwind
Impact of MRD status in patients with AML undergoing allogeneic stem cell transplantation in the first vs the second remission. Blood advances 6 (15) (2022)
Lisa Herrmann, Lara Bischof, Donata Backhaus, Dominic Brauer, Georg-Nikolaus Franke, Vladan Vucinic, Uwe Platzbecker, Sebastian Schwind, Madlen Jentzsch
Outcome prediction by the knowledge bank approach in acute myeloid leukemia patients undergoing allogeneic stem cell transplantation. American journal of hematology 97 (10) (2022)
Madlen Jentzsch, Lara Bischof, Jule Ussmann, Donata Backhaus, Dominic Brauer, Klaus H Metzeler, Maximilian Merz, Vladan Vucinic, Georg-Nikolaus Franke, Marco Herling, Uwe Platzbecker, Sebastian Schwind
Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation. Blood cancer journal 12 (12) (2022)
Madlen Jentzsch, Juliane Grimm, Marius Bill, Johannes Küpper, Donata Backhaus, Dominic Brauer, Julia Schulz, Georg-Nikolaus Franke, Vladan Vucinic, Dietger Niederwieser, Uwe Platzbecker, Sebastian Schwind
Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation. Bone marrow transplantation 56 (10) (2021)
Vladan Vucinic, Leo Ruhnke, Katja Sockel, Maximilian Alexander Röhnert, Donata Backhaus, Dominic Brauer, Georg-Nikolaus Franke, Dietger Niederwieser, Martin Bornhäuser, Christoph Röllig, Uwe Platzbecker, Sebastian Schwind, Madlen Jentzsch
The Diagnostic Red Blood Cell Distribution Width as a Prognostic Factor in Acute Myeloid Leukemia. Blood advances (2021)
Madlen Jentzsch, Juliane Grimm, Marius Bill, Dominic Brauer, Donata Backhaus, Rosmarie Pointner, Karoline Goldmann, Julia Schulz, Dietger Niederwieser, Uwe Platzbecker, Sebastian Schwind
Clinical value of the measurable residual disease status within the ELN2017 risk groups in AML patients undergoing allogeneic stem cell transplantation. American journal of hematology 96 (7) (2021)
Donata Backhaus, Madlen Jentzsch, Lara Bischof, Dominic Brauer, Christina Wilhelm, Julia Schulz, Georg-Nikolaus Franke, Wolfram Pönisch, Vladan Vucinic, Uwe Platzbecker, Sebastian Schwind
Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Cancers 13 (22) (2021)
Madlen Jentzsch, Juliane Grimm, Marius Bill, Dominic Brauer, Donata Backhaus, Julia Schulz, Karoline Goldmann, Dietger Niederwieser, Uwe Platzbecker, Sebastian Schwind
Prognostic relevance of remission and measurable residual disease status in AML patients prior to reduced intensity or non-myeloablative allogeneic stem cell transplantation. Blood cancer journal 11 (4) (2021)
Juliane Grimm, Madlen Jentzsch, Marius Bill, Donata Backhaus, Dominic Brauer, Johannes Küpper, Julia Schulz, Georg-Nikolaus Franke, Vladan Vucinic, Dietger Niederwieser, Uwe Platzbecker, Sebastian Schwind
Clinical implications of SRSF2 mutations in AML patients undergoing allogeneic stem cell transplantation. American journal of hematology 96 (10) (2021)
Madlen Jentzsch, Juliane Grimm, Marius Bill, Dominic Brauer, Donata Backhaus, Karoline Goldmann, Julia Schulz, Dietger Niederwieser, Uwe Platzbecker, Sebastian Schwind
ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation. Bone marrow transplantation 56 (4) (2020)
Madlen Jentzsch, Sebastian Schwind, Enrica Bach, Sebastian Stasik, Christian Thiede, Uwe Platzbecker
Clinical Challenges and Consequences of Measurable Residual Disease in Non-APL Acute Myeloid Leukemia. Cancers 11 (11) (2019)

Madlen Jentzsch.css-eqlu8i{font-size:small;padding-left:4px;} (M Jentzsch)

Publication Activity (10 Years)

Top Topics

Top Venues

Madlen Jentzsch (M Jentzsch)